Net collection, no different inclusions
Injectable GLP-1 agents continue to provide strong efficacy and established cardiovascular benefits with convenient weekly administration
Most people do not notice meaningful appetite suppression until weeks two through four, with full effects emerging over several months as the dose escalates to therapeutic levels
However, lixisenatide inhibited the A-induced activation of GSK-3, with a significant increase in the phosphorylation of ser9 and a significant decrease in the phosphorylation of Y216, suggesting that lixisenatide can prevent A-related impairments by affecting the PI3K-Akt-GSK3 pathway (179)
Hazards of People 65+ Taking GLP-1 Weight Loss Medications We know these GLP-1 weight loss drugs can be effective for older adults, but its not clear how they might affect this population in the long term
GLP-1 receptor agonists are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or in those with Multiple Endocrine Neoplasia type 2 (MEN2), consistent with existing FDA labeling